Matinas BioPharma (MTNB)
NYSE MKT:MTNB
Holding MTNB?
Track your performance easily

Matinas BioPharma (MTNB) Balance Sheet

1,499 Followers

Matinas BioPharma Balance Sheet

Matinas BioPharma's total assets for Q2 2024 were $24.36M, an increase of 24.25% from the previous quarter. MTNB total liabilities were $5.26M for the fiscal quarter, a 4.16% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 25.10M$ 44.82M$ 61.33M$ 70.97M$ 40.24M
Total Liabilities
$ 5.86M$ 8.18M$ 8.83M$ 7.24M$ 7.19M
Total Equity Gross Minority
$ 19.25M$ 36.64M$ 52.49M$ 63.73M$ 33.05M
Total Capitalization
$ 22.14M$ 40.19M$ 52.49M$ 63.73M$ 33.05M
Preferred Stock Equity
---$ 3.80M$ 3.99M
Capital Lease Obligations
---$ 3.75M$ 4.23M
Currency in USD

Matinas BioPharma Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis